Fox Chase Cancer Center Earns Recertification for Palliative Care Program

Marcin Chwistek, MD, FAAHPM, a professor in the Department of Hematology/Oncology and director of the SOPCP
Marcin Chwistek, MD, FAAHPM, a professor in the Department of Hematology/Oncology and director of the SOPCP

PHILADELPHIA (September 15, 2022)—The Supportive Oncology and Palliative Care Program (SOPCP) at Fox Chase Cancer Center has earned Joint Commission Advanced Palliative Care Certification, marking the fourth consecutive time the program has achieved this distinction

“It is very rewarding to receive the prestigious Joint Commission certification,” said Marcin Chwistek, MD, FAAHPM, a professor in the Department of Hematology/Oncology and director of the SOPCP. “It speaks to the high quality of the interdisciplinary care we have been consistently providing to our patients. It also recognizes our team’s efforts and institutional support for palliative care, a crucial aspect of cancer care at Fox Chase.”

The Joint Commission is a nonprofit that accredits and certifies healthcare organizations and programs in the United States and globally. This certificate recognizes the many outstanding qualities that make SOPCP an exceptional palliative care provider.

“There are a lot of factors that affect the final decision about recertification. One aspect that underlies it all, in my view, is our teamwork and high level of integration of palliative care into medical oncology service lines, which I believe is especially strong at Fox Chase,” said Chwistek. 

This year’s recertification was earned amidst a major electronic health records transition, which Chwistek said was a challenge. He said he particularly wanted to thank Kathleen Murphy, CRNP, AOCN, ACHPN.

“Kate has worked tirelessly to ensure a seamless transition. She devoted a lot of energy and effort over the last several years to ensure that our team excels at the standards set by the Joint Commission,” Chwistek said.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427